Blastomycosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Aditya Ganti (talk | contribs)
Aditya Ganti (talk | contribs)
Line 5: Line 5:


===Transmission===
===Transmission===
Infection occurs by inhalation of the fungus from its natural soil habitat.
*Inhalation of the fungus from its natural soil habitat is considered the most significant route of transmission.
Blastomycosis is a [[dimorphic fungi]]. Once inhaled in the lungs, the conidia are mostly destroyed due to their susceptibility to neutrophils, leukocytes and macrophages. This explains the large number of asymptomatic infections from blastomycosis. Sometimes, a few conidia escape this protective mechanism and evolve into their yeast form, which being double walled structures are more resistant to destruction. This conversion releases a glycoprotien [[BAD-1]], which induces humoral and cellular immunity. This eventually manifests as a pyogranulomatous response which contains the infection at the site of entry. However, sometimes they multiply and get disseminate through the blood and lymphatics to other organs, including the skin, bone, genitourinary tract, and brain. The incubation period is about 30 to 100 days.  
*Other less common route of transmission is by cutaneous inoculation through direct skin injury.
===Incubation===
*The incubation period varies from 3 weeks to 3 months after exposure.
===Pathogensis===
*Once inhaled in the lungs, the conidia are mostly destroyed due to their susceptibility to neutrophils, leukocytes and macrophages.  
*However, a few conidia escape this protective mechanism and evolve into yeast form, which being double walled structures are more resistant to destruction.  
*This conversion releases a glycoprotien [[BAD-1]], which induces cell mediated immunity.  
*This results in a pyogranulomatous response at the site of infection (lungs).
*Which eventually leads to the formation of a non-caseating granulomas.
===Dissemination===
*The fungi multiply in the primary foci and can get disseminate through the blood and lymphatics to other organs, including the skin, bone, genitourinary tract.


[[Image:Blastomycosis-lifecycle.jpg|center|frame|Blastomycosis - life cycle and epidemiology]]
[[Image:Blastomycosis-lifecycle.jpg|center|frame|Blastomycosis - life cycle and epidemiology]]

Revision as of 13:49, 27 February 2017

Blastomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blastomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blastomycosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blastomycosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Blastomycosis pathophysiology

CDC on Blastomycosis pathophysiology

Blastomycosis pathophysiology in the news

Blogs on Blastomycosis pathophysiology

Directions to Hospitals Treating Blastomycosis

Risk calculators and risk factors for Blastomycosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]

Overview

Transmission

  • Inhalation of the fungus from its natural soil habitat is considered the most significant route of transmission.
  • Other less common route of transmission is by cutaneous inoculation through direct skin injury.

Incubation

  • The incubation period varies from 3 weeks to 3 months after exposure.

Pathogensis

  • Once inhaled in the lungs, the conidia are mostly destroyed due to their susceptibility to neutrophils, leukocytes and macrophages.
  • However, a few conidia escape this protective mechanism and evolve into yeast form, which being double walled structures are more resistant to destruction.
  • This conversion releases a glycoprotien BAD-1, which induces cell mediated immunity.
  • This results in a pyogranulomatous response at the site of infection (lungs).
  • Which eventually leads to the formation of a non-caseating granulomas.

Dissemination

  • The fungi multiply in the primary foci and can get disseminate through the blood and lymphatics to other organs, including the skin, bone, genitourinary tract.
Blastomycosis - life cycle and epidemiology

References

Template:WS